Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells

  • Wang, Fu (State Key Laboratory of Virology, College of Life Sciences, Wuhan University) ;
  • Fu, Xiang-Dong (Department of Cellular and Molecular Medicine, University of California) ;
  • Zhou, Yu (State Key Laboratory of Virology, College of Life Sciences, Wuhan University) ;
  • Zhang, Yi (State Key Laboratory of Virology, College of Life Sciences, Wuhan University)
  • Published : 2009.11.30


Cyclin E1 (CCNE1), a positive regulator of the cell cycle, controls the transition of cells from G1 to S phase. In numerous human tumors, however, CCNE1 expression is frequently dysregulated, while the mechanism leading to its dysregulation remains incompletely defined. Herein, we showed that CCNE1 expression was subject to post-transcriptional regulation by a microRNA miR-16-1. This was evident at protein level of CCNE1 as well as its mRNA level. Further evident by dual luciferase reporter assay revealed that two evolutionary conserved binding sites on 3' UTR of CCNE1 were the direct functional target sites. Moreover, we showed that miR-16-1 induced G0/G1 cell cycle arrest by targeting CCNE1 and siRNA against CCNE1 partially phenocopied miR-16-1-induced cell cycle phenotype whereas substantially rescued anti-miR-16-1- induced phenotype. Together, all these results demonstrate that miR-16-1 plays a vital role in modulating cellular process in human cancers and indicate the therapeutic potential of miR-16-1 in cancer therapy.


  1. Sauer, K. and Lehner, C. F. (1995) The role of cyclin E in the regulation of entry into S phase. Prog. Cell Cycle Res. 1, 125-139
  2. Arata, Y., Fujita, M., Ohtani, K., Kijima, S. and Kato, J. Y. (2000) Cdk2-dependent and independent pathways in E2Fmediated S phase induction. J. Biol. Chem. 275, 6337-6345
  3. Ma, T., Van Tine, B. A., Wei, Y., Garrett, M. D., Nelson, D., Adams, P. D., Wang, J., Qin, J., Chow, L. T. and Harper, J. W. (2000) Cell cycle-regulated phosphorylation of p220 (NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes & Dev. 14, 2298-2313
  4. Winey, M. (1999) Cell cycle: driving the centrosome cycle. Curr. Biol. 9, R449-452
  5. Ekholm, S. V. and Reed, S. I. (2000) Regulation of G(1) cyclin dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12, 676-684
  6. Donnellan, R. and Chetty, R. (1999) Cyclin E in human cancers. FASEB. J. 13, 773-780
  7. Sandhu, C., and Slingerland, J. (2000) Deregulation of the cell cycle in cancer. Cancer Detect Prev. 24, 107-118
  8. Tarik, M. and Christoph, G. (2004) Cyclin E. Int. J. Biochem. Cell Biol. 36, 1424-1439
  9. Akama, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Kitahara, K., Ishikawa, T. and Tahara, E. (1995) Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res. 86, 617-621
  10. Demetrick, D. J., Matsumoto, S., Hannon, G. J., Okamoto, K., Xiong, Y., Zhang, H. and Beach, D. H. (1995) Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3) Cytogenet. Cell Genetics. 69, 190-192
  11. Botner, D. M., and Rosenberg, M. P. (1997) Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell Biol. 17, 453-459
  12. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
  13. Ambros, V. (2004) The functions of animal microRNAs. Nature 431, 350-355
  14. Cho, W. C. (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 6, 60-67
  15. Gregory, R. I. and Shiekhattar, R. (2005) MicroRNA biogenesis and cancer. Cancer Re. 65, 3509-3512
  16. Linsley, P. S., Schelter, J., Burchard, J., Kibukawa, M., Martin, M. M., Bartz, S. R., Johnson, J. M., Cummins, J. M., Raymond, C. K., Dai, H., Chau, N., Cleary, M., Jackson, A. L., Carleton, M. and Lim, L. (2007) Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell Biol. 27, 2240-2252
  17. Liu, Q., Fu, H., Sun, F., Zhang, H., Tie, Y., Zhu, J., Xing, R., Sun, Z. and Zheng, X. (2008) miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic. Acids. Res. 36, 5391-5404
  18. Bonci, D., Coppola, V., Musumeci, M., Addario, A., Giuffrida, R., Memeo, L., D'Urso, L., Pagliuca, A., Biffoni, M., Labbaye, C., Bartucci, M., Muto, G., Peschle, C. and De Maria, R. (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 14, 1271-1277
  19. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. and Burge, C. B. (2003) Prediction of mammalian micro RNA targets. Cell 115, 787-798
  20. Lall, S., Grun, D., Krek, A., Chen, K., Wang, Y. L., Dewey, C. N., Sood, P., Colombo, T., Bray, N., Macmenamin, P., Kao, H. L., Gunsalus, K. C., Pachter, L., Piano, F. and Rajewsky, N. (2006) A genome-wide map of conserved microRNA targets in C. elegans. Curr. Biol., 16, 460-471
  21. Bino, J., Anton, J. E., Alexei, A., Thomas, T., Chris, S. and Debora, S. M. (2004) Human microRNA targets. PLoS Biol. 2, e363
  22. Nam, S., Kim, B., Shin, S. and Lee, S. (2008) miRGator: an integrated system for functional annotation of micro RNAs. Nucleic. Acids. Res. 36, 159-164
  23. Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., Rassenti, L., Kipps, T., Negrini, M., Bullrich, F. and Croce, C. M. (2002) Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99, 15524-15529
  24. Bottoni, A., Piccin, D., Tagliati, F., Luchin, A., Zatelli, M. C. and degli Uberti, E. C. (2005) miR-15a and miR-16-1 down-regulation in pituitary adenomas. J. Cell Physiol. 204, 280-285
  25. Kr$\ddot{u}$ger, J. and Rehmsmeier, M. (2006) RNAhybrid: micro-RNA target prediction easy, fast and flexible. Nucleic. Acids Res. 34, 451-454
  26. Doench, J. G. and Sharp P. A. (2004) Specificity of micro- RNA target selection in translational repression. Genes & Dev. 18, 504-511
  27. Carleton, M., Cleary, M. A. and Linsley, P. S. (2007) Micro RNAs and cell cycle regulation. Cell Cycle 6, 2127- 2132
  28. Moosavi M. A, Yazdanparast, R. and Lotfi, A. (2006) GTP induces S-phase cell-cycle arrest and inhibits DNA synthesis in K562 cells but not in normal human peripheral lymphocytes. J. Biochem. Mol. Biol. 39, 492-501
  29. Gong, L., Jiang, C., Zhang, B., Hu, H., Wang, W. and Liu, X. (2006) Adenovirus-mediated expression of both antisense ornithine decarboxylase and s-denosylmethionine decarboxylase induces G1 arrest in HT-29 cells. J. Biochem. Mol. Biol. 39, 730-736

Cited by

  1. Functional validation of microRNA-target RNA interactions vol.58, pp.2, 2012,
  2. miR-15/16 complex targets p70S6 kinase1 and controls cell proliferation in MDA-MB-231 breast cancer cells vol.552, pp.2, 2014,
  3. MicroRNA-16 Modulates HuR Regulation of Cyclin E1 in Breast Cancer Cells vol.16, pp.4, 2015,
  4. Metapristone (RU486 derivative) inhibits cell proliferation and migration as melanoma metastatic chemopreventive agent vol.90, 2017,
  5. Regulation of proliferation and apoptosis in human osteoblastic cells by microRNA-15b vol.79, 2015,
  6. Signaling pathways in HPV-associated cancers and therapeutic implications vol.25, 2015,
  7. miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression vol.32, pp.7, 2011,
  8. The hunting of targets: challenge in miRNA research vol.27, pp.1, 2013,
  9. MicroRNA 16 enhances differentiation of human bone marrow mesenchymal stem cells in a cardiac niche toward myogenic phenotypes in vitro vol.90, pp.25-26, 2012,
  10. Role of microRNAs in skeletal muscle development and rhabdomyosarcoma (Review) vol.11, pp.6, 2015,
  11. A multi-targeted approach to suppress tumor-promoting inflammation vol.35, 2015,
  12. MicroRNAs as new player in rheumatoid arthritis vol.78, pp.1, 2011,
  13. Anti-Tumor Activity of Eurycoma longifolia Root Extracts against K-562 Cell Line: In Vitro and In Vivo Study vol.9, pp.1, 2014,
  14. Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro vol.82, pp.7, 2014,
  15. Mir-33 regulates cell proliferation and cell cycle progression vol.11, pp.5, 2012,
  16. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter vol.8, pp.14, 2016,
  17. MicroRNAs and the cell cycle vol.1812, pp.5, 2011,
  18. Les microARN : de nouveaux acteurs de la polyarthrite rhumatoïde vol.78, pp.2, 2011,
  19. c-MYC–miRNA circuitry vol.13, pp.2, 2014,
  20. CPEB and miR-15/16 Co-Regulate Translation of Cyclin E1 mRNA during Xenopus Oocyte Maturation vol.11, pp.2, 2016,
  21. Identification of microRNA-mRNA modules using microarray data vol.12, pp.1, 2011,
  22. Characterization of microRNA expression in serous ovarian carcinoma vol.34, pp.2, 2014,
  23. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development vol.14, pp.3, 2012,
  24. The Induction of microRNA-16 in Colon Cancer Cells by Protein Arginine Deiminase Inhibition Causes a p53-Dependent Cell Cycle Arrest vol.8, pp.1, 2013,
  25. miRNAs and related polymorphisms in rheumatoid arthritis susceptibility vol.11, pp.9, 2012,
  26. microRNA and transcription factor mediated regulatory network for ovarian cancer vol.34, pp.5, 2013,
  27. miRNA response to DNA damage vol.36, pp.9, 2011,
  28. MicroRNA aberrations: An emerging field for gallbladder cancer management vol.22, pp.5, 2016,
  29. Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1* vol.32, pp.4, 2011,
  30. A Re-Examination of Global Suppression of RNA Interference by HIV-1 vol.6, pp.2, 2011,
  31. Down-regulation of cyclin E1 expression by microrna-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation vol.226, pp.10, 2011,
  32. Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell vol.45, pp.10, 2017,
  33. FXR1a-associated microRNP: A driver of specialized non-canonical translation in quiescent conditions vol.14, pp.2, 2017,
  34. Acute kidney injury: a paradigm for miRNA regulation of the cell cycle vol.42, pp.4, 2014,
  35. Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression vol.3, pp.1, 2015,
  36. The miR-15/107 Group of MicroRNA Genes: Evolutionary Biology, Cellular Functions, and Roles in Human Diseases vol.402, pp.3, 2010,
  37. Noncoding RNAs in DNA Repair and Genome Integrity vol.20, pp.4, 2014,
  38. /S phase cyclin, CCNE1, is lost in osteosarcomas vol.292, pp.52, 2017,
  39. Omega-3 fatty acid DHA modulates p53, survivin, and microRNA-16-1 expression in KRAS-mutant colorectal cancer stem-like cells vol.13, pp.1, 2018,